Silvio Inzucchi, MD
Cards
Contact/Administration
Research
About
Contact/Administration
Research
About
Contact/Administration
Contact Info
Publications Overview
- 193 Publications
- 10,928 Citations
- 58 Yale Co-Authors
Titles
Professor of Medicine (Endocrinology)
Appointments
Contact Info
Publications Overview
- 193 Publications
- 10,928 Citations
- 58 Yale Co-Authors
Titles
Professor of Medicine (Endocrinology)
Appointments
Contact Info
About
Copy Link
Titles
Professor of Medicine (Endocrinology)
Biography
Dr. Inzucchi received his undergraduate degree from Fordham University in New York City and his M.D. degree from Harvard Medical School in Boston, Massachusetts. He completed his residency in Internal Medicine and his post-doctoral Fellowship in Endocrinology and Metabolism at Yale-New Haven Hospital, in New Haven, Connecticut, USA. He is currently Professor of Medicine at the Yale University School of Medicine in New Haven, where he serves as Clinical Chief of the Section of Endocrinology, Medical Director of the Yale Diabetes Center, and Program Director of the Endocrinology & Metabolism Fellowship.
Dr. Inzucchi has been an invited lecturer both nationally and internationally on many topics, most pertaining to clinical diabetes management. He has authored or co-authored more than 500 manuscripts, chapters, monographs, and abstracts, some published in the most prestigious medical journals, including the New England Journal of Medicineand JAMA. A former member of the editorial board of Diabetes Careand Associate Editor of the Journal of Clinical Endocrinology and Metabolism, Dr. Inzucchi served as co-chair of the writing group for the 2012 and 2015 ADA-EASD Position Statements on the Management of Hyperglycemia in Type 2 Diabetes.
His current research interests include pharmacological antihyperglycemic therapy in both the inpatient and outpatient settings; and the link between type 2 diabetes, insulin resistance, and cardiovascular complications. He has held leadership roles in several large clinical trials related to diabetes medications and their cardiovascular impact.
Dr. Inzucchi also has a large academic clinical practice involving a wide spectrum of patients with endocrine diseases, with a focus on diabetes and pituitary and adrenal diseases.
Appointments
Endocrinology
ProfessorPrimary
Other Departments & Organizations
Education & Training
- MD
- Harvard University (1985)
- BS
- Fordham University (1981)
Research
Copy Link
Overview
Medical Research Interests
ORCID
0000-0003-1254-6636
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Priyadarshini Balasubramanian, MD
Adam de Havenon, MD, MS
Barbara Gulanski, MD, MPH
F. Perry Wilson, MD, MSCE
Frans Wackers, MD, PhD
Harlan Krumholz, MD, SM
Diabetes Mellitus
Hyperglycemia
Atherosclerosis
Publications
2026
Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease
Cavender M, Marx N, Mulvagh S, Deanfield J, Buse J, Inzucchi S, Pop-Busui R, Mann J, Emerson S, Poulter N, Engelmann M, Hovingh G, Lorenzatti A, Oguz A, Saraiva J, Garcia R, Hoff S, Musinga D, Bonaca M, Arslan E, McGuire D, Group S. Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease. Journal Of The American College Of Cardiology 2026, 87: 1369-1373. DOI: 10.1016/j.jacc.2025.12.071.Peer-Reviewed Original ResearchAltmetricOral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes
Pop-Busui R, Rasmussen S, Deanfield J, Buse J, Marx N, Mulvagh S, Inzucchi S, Mann J, Emerson S, Poulter N, Engelmann M, Hovingh G, Bayer Tanggaard K, Birkenfeld A, Connelly K, Haluzik M, Cavender M, Kellerer M, Jhund P, Gregersen S, Nielsen O, Lam C, McGuire D, Schelde P, Amod A, Mankovsky B, Desouza C, Gorgojo-Martinez J, Arechavaleta R, Tu S, Francisco J, Sánchez García R, Chun Chung Chow F, Watada H, Yoon K, Perez Manghi F, Pozzi J, Lorenzatti A, Visco V, Piskorz D, Nardone L, Chahin M, Bustamante Labarta M, Luquez C, MacKinnon I, Pieber T, Prager R, Fließer-Görzer E, Ebenbichler C, Fasching P, Mathieu C, De Block C, Duyck F, Heyns E, Lapauw B, Turatti L, Franco D, Rea R, Kurtz Lisboa H, Salles J, Saraiva J, Fonseca A, Vidotti M, Leite S, Aggarwal N, Bajaj H, Schlosser R, Noronha L, Pedersen S, Tellier G, Weisnagel J, Beca S, Alasaad H, Punthakee Z, Mancini J, Tytus R, Ransom T, Husain M, Tsoukas M, Ji L, Liu J, Yuan G, Ye X, Dong X, Bian F, Angelo Cadena Bonfanti A, Hernandez Erazo I, Hernández Ruiz E, Gómez Mesa J, Canecki-Varzic S, Vucak Loncar J, Simegi-Djekic V, Ticinovic Kurir T, Tusek S, Rahelic D, Marusic S, Kruljac I, Fabris Vitkovic D, Oznerova M, Vrkoc J, Doležalová B, Jankovec Z, Olsovsky J, Zemanova J, Kyselova P, Šmahelová A, Olsen A, Mikkelsen D, Egstrup K, Pedersen-Bjergaard U, Potier L, Borot S, Gaborit B, Monier A, Pradignac A, Verges B, Larroumet A, Thuan J, Lüdemann J, Esser M, Kahrmann G, Kempe H, Koch T, Axthelm C, Paschen B, Rose L, Schaum T, Schulze J, Staudenmeyer A, Wenzl-Bauer V, Ma R, Thomas N, Mohan V, Reddy V, Rao P, Sahay R, Singh J, Prakash A, Tandon N, Marwah T, Chaudhury T, Ghosh S, Kanungo A, Mittal N, Jacob J, Chadha M, Bhagwat N, Jain S, Thulaseedharan N, Girithara G, Desai A, Sharma S, Murthy S, Sethi B, Kadam Y, Kesavadev J, Daxini B, Chawla R, Gopalakrishnan U, Baruah M, Reddy S, Suryanarayana K, Singh K, Saboo B, Aharon-Hananel G, Hochberg I, Sofer Y, Tirosh A, Shimon I, Vishlitzky V, Bashkin A, Tsur A, Shechter M, Andreozzi F, Setola E, Consoli A, Lupoli R, Genovese S, Maranghi M, Lauro D, Citarrella R, Fadini G, Murdolo G, Di Carlo A, Giorgino F, Buscemi S, Hanaoka K, Osonoi T, Ohashi H, Ezaki H, Yuki H, Kiyosue A, Hata Y, Sugawara M, Domae H, Iwata H, Nishida Y, Igarashi M, Fujino S, Oiwa A, Oh F, Sueyoshi A, Murakami T, Tanaka M, Idogaki A, Onaka H, Mizote I, Doi M, Ebisui O, Tanabe M, Natsuaki M, Jinnouchi H, Nakamura S, Wan Mohamed W, Yahaya N, Ratnasingam J, Ong T, Mohamad M, Yusoff Azmi Merican N, Abdul Ghani R, Adam N, Fam T, Tan F, Morales Villegas E, Gonzalez-Galvez G, Espinoza Peralta D, Medina Pech C, García Ulloa A, Laviada Molina H, Banda Elizondo R, Garza Ruiz J, García Cantú E, van Bemmel T, de Valk H, Kooy A, Lieverse L, Landewe-Cleuren S, Hoogenberg K, van Raalte D, Jebbink M, Oldenburg-Ligtenberg C, Abbink-Zandbergen E, Mihai B, Crisan C, Filip I, Busegeanu M, Roman G, Mot A, Nicoara A, Anghel V, Pletea N, Suciu M, Strajer D, Cernea S, Zilov A, Kobalava Z, Ruyatkina L, Suplotova L, Sergeeva-Kondrachenko M, Yanovskaya M, Kargina L, Ignatyeva A, Astamirova K, Zalevskaya A, Zagrebelnaya O, Frolova E, Peskov A, Mishchenko (Golinskaya) O, Otroshchenko O, Gaysina L, Shabelnikova O, Saprina T, Lysenko T, Kunitsyna M, Zyangirova S, Lalic N, Lalic K, Beljic Zivkovic T, Kikovic S, Djukic A, Pesic M, Dimic D, Stokic E, Mitrovic M, Polovina S, Djordjevic M, Sosovec D, Pella D, Donicova V, Hanackova Prasekova S, Koleny D, Culak J, Cerna K, Hundza V, Gmitrov J, Lacka J, Plasil R, Bacus H, Bhorat Q, Joshi P, Lakha D, Makan V, Ntusi N, Padayachee T, Seeber M, Pillay D, Joshi M, Mayet L, Lee J, Kim S, Min K, Kang E, Lee W, Choi S, Lee C, López Suárez A, García Ordóñez M, García Quintana A, Mazón Ramos P, Cigarrán S, Barrios C, Soto González A, Jodar E, Delgado Lista J, Morales Portillo C, Montalbán Carrasco C, Tinahones F, Huang C, Chen S, Buranasupkajorn P, Sriwijitkamol A, Buranapin S, Suwanagool A, Tantiwong P, Boonyavarakul A, Benjachareonwong S, Leelawattana R, Vathesatogkit P, Deerochanawong C, Sonmez Y, Oguz A, Tabak O, Kocak M, Sariakcali B, Bayram F, Guclu M, Gurkan E, Kebapci N, Comlekci A, Acibucu F, Ahbab S, Bilen H, Urbanovych A, Kuskalo P, Bondarets I, Petrosyan O, Pashkovska N, Oleksyk O, Kaydashev I, Maliar K, Myshanych G, Bain S, Black D, Johnston P, Dang C, Dhatariya K, English P, Field B, Grimmer P, Gunstone A, Ray S, Tatovic D, Kernohan A, Lindsay R, Mcknight J, Park A, Patel D, Philip S, Randeva H, Sathyapalan T, Turner W, Wyatt N, Allison D, Awasty V, Ayele E, Bajaj C, Budoff M, Busch R, Casaubon L, Chaidarun S, Chochinov R, Chu J, Daboul N, Dang A, Everhart B, Arambasick J, Fink R, Fitz-Patrick D, Fogarty C, Gilbert M, Johnson D, Krishnasamy S, Lane W, Nakhle S, Levenson D, O’Donnell P, Weiss D, Risser J, Wierum C, Sivalingam K, Gupta D, Philis-Tsimikas A, Pratley R, Mirza L, Snyder B, Rasouli N, Porter J, Ledesma G, Powell T, Tandron I, Lingvay I, Reed J, Patel M, Lovre D, Chaicha-Brom T, Jantzi C, Brautigam D, Bao S, Mbogua C, Zemel L, Hasan S, Rosenstock J, Tran H, Poremba J, Baker C, Prier K, Chilka S, Agaiby J, Condit J, Eagerton D, Huffman D, Cornett G, Traylor H, Brinson C, Bays H, Jerkins T, Nicol P, Siddiqui I, Hewitt M, Odugbesan A, Lillestol M, Thrasher J, Gandy W, Pant N, Nagelberg S, Cannon K, Anderson M, Bhargava A, Doshi A, Jardula M, Montero M, Purighalla R, Warren M, Harris K, Jackson R, Khaira A, Gonzalez-Orozco L, Gagianas P, Pantalone K, Murray A. Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes. JAMA Internal Medicine 2026, 186 PMID: 41627802, PMCID: PMC12865694, DOI: 10.1001/jamainternmed.2025.7774.Peer-Reviewed Original ResearchCitationsAltmetricConceptsOral semaglutideHeart failureHF historyChronic kidney diseaseAtherosclerotic CV diseaseHF outcomesType 2 diabetesHazard ratioHF eventsEjection fractionCV diseaseClinical trialsEffects of oral semaglutideOnce-daily oral semaglutideRisk reduction of MACEKidney diseaseRisk of serious adverse eventsComplications of type 2 diabetesHistory of HFSerious adverse eventsSecondary analysisReduction of MACEHeart failure outcomesStandard of careAdverse event occurrenceFinerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY
Weingold R, Filippatos G, Anker S, Wanner C, Shafi T, Tangri N, Pitt B, Brinker M, Scott C, Roberts L, Rossing P, Inzucchi S, Investigators F. Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY. Journal Of Diabetes And Its Complications 2026, 40: 109274. PMID: 41679125, DOI: 10.1016/j.jdiacomp.2026.109274.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsUrine albumin-to-creatinine ratioEstimated glomerular filtration rateChronic kidney diseaseKDIGO risk categoriesAssociated with lower riskType 2 diabetesCategory improvementUrine albumin-to-creatinine ratio changesKidney diseaseChronic kidney disease progression risksAlbumin-to-creatinine ratioRisk of CV eventsPost hoc subanalysisRisk categoriesCV composite outcomeGlomerular filtration rateComposite outcome riskLow likelihoodAssociated with greater improvementFIDELIO-DKDFIGARO-DKDProgression riskComposite outcomeCV eventsFinerenoneSGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria
Neuen B, Fletcher R, Anker S, Bhatt D, Butler J, Cherney D, Docherty K, Inzucchi S, Jardine M, Mahaffey K, McCausland F, McGuire D, McMurray J, Neal B, Packer M, Patel S, Perkovic V, Sabatine M, Sardell R, Solomon S, Vaduganathan M, Wanner C, Wheeler D, Zannad F, Haynes R, Staplin N, Herrington W, Heerspink H, Neuen B, Heerspink H, Anker S, Bhatt D, Butler J, Cherney D, Docherty K, Hernandez A, Herrington W, Inzucchi S, James S, Jardine M, Mahaffey K, McGuire D, McMurray J, Neal B, Packer M, Patel S, Perkovic V, Sabatine M, Staplin N, Solomon S, Vaduganathan M, Wanner C, Wheeler D, Zannad F. SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria. JAMA: The Journal Of The American Medical Association 2026, 335: 233-244. PMID: 41203232, PMCID: PMC12595549, DOI: 10.1001/jama.2025.20834.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSodium-glucose cotransporter 2 inhibitorsEstimated glomerular filtration rateSodium-glucose cotransporter 2Urinary albumin-to-creatinine ratioChronic kidney disease progressionChronic kidney diseaseBaseline estimated glomerular filtration rateAnnual rate of eGFR declineRate of eGFR declineRisk of CKD progressionGlomerular filtration rateStage 4 CKDKidney outcomesKidney failureType 2 diabetesEGFR declineCKD progressionHeart failureFiltration rateSpectrum of kidney functionMonths of follow-upAlbumin-to-creatinine ratioEffects of SGLT2 inhibitorsPlacebo-controlled trialDegree of albuminuriaEffects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria
Staplin N, Roddick A, Neuen B, Anker S, Bhatt D, Butler J, Cherney D, Docherty K, Fletcher R, Inzucchi S, Jardine M, Mahaffey K, McGuire D, McMurray J, Neal B, Packer M, Patel S, Perkovic V, Sabatine M, Solomon S, Vaduganathan M, Wanner C, Wheeler D, Zannad F, Haynes R, Heerspink H, Herrington W, Neuen B, Heerspink H, Anker S, Bhatt D, Butler J, Cherney D, Docherty K, Hernandez A, Herrington W, Inzucchi S, James S, Jardine M, Mahaffey K, McGuire D, McMurray J, Neal B, Patel S, Perkovic V, Sabatine M, Staplin N, Solomon S, Vaduganathan M, Wanner C, Wheeler D, Zannad F. Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria. JAMA: The Journal Of The American Medical Association 2026, 335: 220-232. PMID: 41202026, PMCID: PMC12595550, DOI: 10.1001/jama.2025.20835.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsUrine albumin-to-creatinine ratioSodium-glucose cotransporter 2 inhibitorsSodium-glucose cotransporter 2Levels of urine albumin to creatinine ratioKidney disease progressionAbsolute benefitDiabetes statusSGLT2 inhibitorsEffects of sodium-glucose cotransporter 2Effects of sodium-glucose cotransporter 2 inhibitorsDisease progressionKidney diseaseRates of acute kidney injurySafety outcomesAlbumin-to-creatinine ratioEffects of SGLT2 inhibitorsBenefits of SGLT2 inhibitorsBaseline levelsSGLT2 inhibitor useAcute kidney injuryLevels of albuminuriaChronic kidney diseaseRandomized clinical trialsInverse variance-weighted meta-analysisStrength of recommendations10 Effect of Glucose Management on Coronary Heart Disease Risk in Patients With Type 2 Diabetes
Lipska K, Inzucchi S. 10 Effect of Glucose Management on Coronary Heart Disease Risk in Patients With Type 2 Diabetes. 2026, 151-169. DOI: 10.1016/b978-0-323-87862-3.00010-0.ChaptersConceptsCoronary heart diseaseCoronary heart disease eventsImpact of interventionsRisk of CHD eventsCoronary heart disease riskCoronary heart disease outcomesHeart disease riskCHD eventsType 2 diabetesDisease riskClinical trial evidencePatient outcomesRisk factorsTrial evidenceGlucose managementHemoglobin A1cClinical practiceHeart diseaseDevelopment of diabetesPatient populationComplications of diabetesDiabetesInterventionRiskOutcomes12 Cardiovascular and Kidney Effects of Sodium Glucose Cotransporter Inhibitors
Inzucchi S, Kosiborod M. 12 Cardiovascular and Kidney Effects of Sodium Glucose Cotransporter Inhibitors. 2026, 180-192. DOI: 10.1016/b978-0-323-87862-3.00012-4.Peer-Reviewed Original Research
2025
Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial
Mann J, Marx N, Deanfield J, Emerson S, Inzucchi S, McGuire D, Mulvagh S, Pop-Busui R, Poulter N, Engelmann M, Hovingh G, Belmar N, Idorn T, Jeppesen O, Birkenfeld A, Amod A, Mankovsky B, Desouza C, Gorgojo-Martinez J, Arechavaleta R, Tu S, Buse J, McGuire D, Buse J, Mann J, Marx N, Deanfield J, Emerson S, Inzucchi S, Mulvagh S, Pop-Busui R, Poulter N, Engelmann M, Hovingh G, Schelde P, Birkenfeld A, Amod A, Mankovsky B, Desouza C, Gorgojo-Martinez J, Arechavaleta R, Tu S, Francisco J, García R, Chow F, Watada H, Yoon K, Singh P, Matthew, Manghi F, Pozzi J, Lorenzatti A, Visco V, Piskorz D, Nardone L, Chahin M, Labarta M, Luquez C, MacKinnon I, Pieber T, Prager R, Fließer-Görzer E, Ebenbichler C, Fasching P, Mathieu C, De Block C, Duyck F, Heyns E, Lapauw B, Turatti L, Franco D, Rea R, Lisboa R, Salles J, Saraiva J, Fonseca A, Vidotti M, Leite S, Aggarwal N, Bajaj H, Schlosser R, Noronha L, Pedersen S, Peterson S, Tellier G, Weisnagel J, Beca S, Alasaad H, Punthakee Z, Mancini J, Tytus R, Ransom T, Connelly K, Husain M, Tsoukas M, Ji L, Liu J, Yuan G, Ye X, Dong X, Bian F, Angelo A, Garcia R, Erazo I, Ruiz E, Mesa J, Canecki-Varzic S, Loncar J, Simegi-Djekic V, Kurir T, Tusek S, Rahelic D, Marusic S, Kruljac I, Vitkovic D, Oznerova M, Vrkoc J, Doležalová B, Haluzik M, Jankovec Z, Olsovsky J, Zemanova J, Kyselova P, Smahelova A, Gregersen S, Olsen A, Mikkelsen D, Egstrup K, Pedersen-Bjergaard U, Potier L, Borot S, Gaborit B, Monier A, Pradignac A, Verges B, Larroumet A, Thuan J, Kellerer M, Lüdemann J, Esser M, Kahrmann G, Kempe H, Koch T, Axthelm C, Paschen B, Rose L, Schaum T, Schulze J, Staudenmeyer A, Wenzl-Bauer V, W. R, Thomas N, Mohan V, Reddy V, Rao P, Sahay R, Singh J, Prakash A, Tandon N, Marwah T, Chaudhury T, Ghosh S, Kanungo A, Mittal N, Jacob J, Chadha M, Chawla M, Bhagwat N, Jain S, Thulaseedharan N, Girithara G, Desai A, Sharma S, Murthy S, Sethi B, Kadam Y, Kesavadev J, Daxini B, Chawla R, Gopalakrishnan U, Baruah M, Reddy S, Suryanarayana K, Singh K, Saboo B, Aharon-Hananel G, Hochberg I, Sofer Y, Tirosh A, Shimon I, Vishlitzky V, Bashkin A, Tsur A, Shechter M, Andreozzi F, Setola E, Consoli A, Lupoli R, Genovese S, Maranghi M, Lauro D, Citarrella R, Fadini G, Murdolo G, Di Carlo A, Giorgino F, Buscemi S, Hanaoka K, Osonoi T, Ohashi H, Ezaki H, Yuki H, Kiyosue A, Hata Y, Sugawara M, Domae H, Iwata H, Nishida Y, Igarashi M, Fujino S, Oiwa A, Oh F, Sueyoshi A, Murakami T, Tanaka M, Idogaki A, Onaka H, Mizote I, Doi M, Ebisui O, Tanabe M, Natsuaki M, Jinnouchi H, Nakamura S, Mohamed W, Yahaya N, Ratnasingam J, Ong T, Mohamad M, Merican N, Ghani R, Adam N, Fam T, Tan F, Villegas E, Gonzalez-Galvez G, Peralta D, Pech C, Ulloa A, Molina H, Elizondo R, Ruiz J, Cantú E, van Bemmel T, de Valk H, Kooy A, Lieverse L, Landewe-Cleuren S, Hoogenberg K, van Raalte D, Jebbink M, Oldenburg-Ligtenberg C, Abbink-Zandbergen E, Mihai B, Crisan C, Filip I, Busegeanu M, Roman G, Mot A, Nicoara A, Anghel V, Pletea N, Suciu M, Strajer D, Cernea S, Zilov A, Kobalava Z, Ruyatkina L, Suplotova L, Sergeeva-Kondrachenko M, Yanovskaya M, Kargina L, Ignatyeva A, Astamirova K, Zalevskaya A, Zagrebelnaya O, Frolova E, Peskov A, Mishchenko O, Otroshchenko O, Gaysina L, Shabelnikova O, Saprina T, Lysenko T, Kunitsyna M, Zyangirova S, Lalic N, Lalic K, Zivkovic T, Kikovic S, Djukic A, Pesic M, Dimic D, Stokic E, Mitrovic M, Polovina S, Djordjevic M, Sosovec D, Pella D, Donicova V, Prasekova S, Koleny D, Culak J, Cerna K, Hundza V, Gmitrov J, Lacka J, Plasil R, Bacus H, Bhorat Q, Joshi P, Lakha D, Makan V, Ntusi N, Padayachee T, Seeber M, Pillay D, Joshi M, Mayet L, Lee J, Kim S, Min K, Kang E, Lee W, Choi S, Lee C, Suárez A, Ordóñez M, Quintana A, Ramos P, Cigarrán S, Barrios C, González A, Jodar E, Lista J, Portillo C, Carrasco C, Tinahones F, Cigarrán S, Huang C, Chen S, Buranasupkajorn P, Sriwijitkamol A, Buranapin S, Suwanagool A, Tantiwong P, Boonyavarakul A, Benjachareonwong S, Leelawattana R, Vathesatogkit P, Deerochanawong C, Sonmez Y, Oguz A, Tabak O, Kocak M, Sariakcali B, Bayram F, Guclu M, Gurkan E, Kebapci N, Comlekci A, Acibucu F, Ahbab S, Bilen H, Urbanovych A, Kuskalo P, Bondarets I, Petrosyan O, Pashkovska N, Oleksyk O, Kaydashev I, Maliar K, Myshanych G, Bain S, Black D, Johnston P, Dang C, Dhatariya K, English P, Field B, Grimmer P, Gunstone A, Ray S, Tatovic D, Kernohan A, Lindsay R, Mcknight J, Park A, Patel D, Philip S, Randeva H, Sathyapalan T, Turner W, Wyatt N, Allison D, Awasty V, Ayele E, Bajaj C, Budoff M, Busch R, Casaubon L, Chaidarun S, Chochinov R, Chu J, Daboul N, Dang A, Everhart B, Arambasick J, Fink R, Fitz-Patrick D, Fogarty C, Gilbert M, Johnson D, Krishnasamy S, Lane W, Nakhle S, Levenson D, O’Donnell P, Weiss D, Risser J, Wierum C, Sivalingam K, Gupta D, Philis-Tsimikas A, Pratley R, Mirza L, Snyder B, Rasouli N, Porter J, Ledesma G, Powell T, Tandron I, Lingvay I, Reed J, Patel M, Lovre D, Chaicha-Brom T, Jantzi C, Brautigam D, Bao S, Mbogua C, Zemel L, Hasan S, Rosenstock J, Tran H, Poremba J, Baker C, Prier K, Chilka S, Agaiby J, Condit J, Eagerton D, Huffman D, Cornett G, Traylor H, Brinson C, Bays H, Jerkins T, Nicol P, Siddiqui I, Hewitt M, Odugbesan A, Lillestol M, Thrasher J, Gandy W, Pant N, Nagelberg S, Cannon K, Anderson M, Bhargava A, Doshi A, Jardula M, Montero M, Purighalla R, Warren M, Harris K, Jackson R, Khaira A, Gonzalez-Orozco B, Gagianas P, Pantalone K, Murray A. Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial. Diabetes Care 2025, 49: 257-265. PMID: 41380027, PMCID: PMC12824789, DOI: 10.2337/dc25-1080.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsChronic kidney diseaseAtherosclerotic cardiovascular diseaseOral semaglutideKidney outcomesType 2 diabetesEGFR declineEffects of oral semaglutideDouble-Blind Randomized Controlled TrialAnnual eGFR declineRandomized Controlled TrialsFollow-upPrespecified subgroupsRandomized trialsSemaglutideKidney diseasePlaceboCardiovascular diseaseEGFROutcomesT2DKidneyDiseaseTrialsIodine for the Outpatient Management of Graves’ Disease: A Case Series of 7 Patients
Magvanjav O, MacLeod R, Balasubramanian P, Mekala K, Peter P, Inzucchi S, Majumdar S. Iodine for the Outpatient Management of Graves’ Disease: A Case Series of 7 Patients. AACE Clinical Case Reports 2025, 13: 83-87. PMID: 41641309, PMCID: PMC12866150, DOI: 10.1016/j.aed.2025.10.015.Peer-Reviewed Case Reports and Technical NotesConceptsGraves' diseaseRadioactive iodineOutpatient managementManagement of Graves' diseaseBridge to surgeryMean treatment durationChemotherapy-induced pancytopeniaThyroid hormone levelsDose of iodineDefinitive treatmentCase seriesSafety profileHormone elevationUncontrolled hyperthyroidismHormone levelsThionamidesTreatment durationSurgeryPatientsAlternative treatmentPropylthiouracilMonotherapyDiseaseTherapyTreatmentDifferences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort
Pop-Busui R, Rosin S, Butera N, Krause-Steinrauf H, Abou Assi H, Garg R, Inzucchi S, Katona A, McGill J, Mudaliar S, Schade D, Seaquist E, Tiktin M, Soliman E, Green J, Crandall J, McKee M, Behringer-Massera S, Brown-Friday J, Xhori E, Ballentine-Cargill K, Duran S, Estrella H, Gonzalez de la torre S, Lukin J, Phillips L, Burgess E, Olson D, Rhee M, Wilson P, Raines T, Boers J, Costello J, Maher-Albertelli M, Mungara R, Savoye L, White C, Gullett C, Holloway L, Morehead F, Person S, Sibymon M, Tanukonda S, Adams C, Ross A, Balasubramanyam A, Gaba R, Gonzalez Hattery E, Ideozu A, Jimenez J, Montes G, Wright C, Hollander P, Roe E, Jackson A, Smiley A, Burt P, Estrada L, Chionh K, Ismail-Beigi F, Falck-Ytter C, Sayyed Kassem L, Sood A, Tiktin M, Kulow T, Newman C, Stancil K, Cramer B, Iacoboni J, Kononets M, Sanders C, Tucker L, Werner A, Maxwell A, McPhee G, Patel C, Colosimo L, Krol A, Goland R, Pring J, Alfano L, Kringas P, Hausheer C, Tejada J, Gumpel K, Kirpitch A, Schneier H, Green J, AbouAssi H, Chatterjee R, Feinglos M, English Jones J, Khan S, Kimpel J, Zimmer R, Furst M, Satterwhite B, Thacker C, Evans Kreider K, Mariash C, Mather K, Ismail H, Lteif A, Mullen M, Hamilton T, Patel N, Riera G, Jackson M, Pirics V, Aguillar D, Howard D, Hurt S, Bergenstal R, Carlson A, Martens T, Johnson M, Hill R, Hyatt J, Jensen C, Madden M, Martin D, Willis H, Konerza W, Yang S, Kleeberger K, Passi R, Fortmann S, Herson M, Mularski K, Glauber H, Prihoda J, Ash B, Carlson C, Ramey P, Schield E, Torgrimson-Ojerio B, Arnold K, Kauffman B, Panos E, Sahnow S, Bays K, Berame K, Cook J, Ghioni D, Gluth J, Schell K, Criscola J, Friason C, Jones S, Nazarov S, Barzilay J, Rassouli N, Puttnam R, Ojoawo B, Nelson R, Curtis M, Hollis B, Sanders-Jones C, Stokes K, El-Haqq Z, Kolli A, Tran T, Wexler D, Larkin M, Meigs J, Chambers B, Dushkin A, Rocchio G, Yepes M, Steiner B, Dulin H, Cayford M, Chu K, DeManbey A, Hillard M, Martin K, Thangthaeng N, Gurry L, Kochis R, Raymond E, Ripley V, Stevens C, Park J, Aroda V, Ghazi A, Magee M, Ressing A, Loveland A, Hamm M, Hurtado M, Kuhn A, Leger J, Manandhar L, Mwicigi F, Sanchez O, Young T, Garg R, Lagari-Libhaber V, Florez H, Valencia W, Marks J, Casula S, Oropesa-Gonzalez L, Hue L, Cuadot A, Nieto-Martinez R, Riccio Veliz A, Gutt M, Kendal Y, Veciana B, Ahmann A, Aby-Daniel D, Joarder F, Morimoto V, Sprague C, Yamashita D, Cady N, Rivera-Eschright N, Kirchhoff P, Morales Gomez B, Adducci J, Goncharova A, Hox S, Petrovitch H, Matwichyna M, Jenkins V, Broadwater L, Ishii R, Bermudez N, Hsia D, Cefalu W, Greenway F, Waguespack C, King E, Fry G, Dragg A, Gildersleeve B, Arceneaux J, Haynes N, Thomassie A, Pavlionis M, Bourgeois B, Hazlett C, Mudaliar S, Henry R, Boeder S, Pettus J, Diaz E, Garcia-Acosta D, Maggs S, DeLue C, Stallings A, Castro E, Hernandez S, Krakoff J, Curtis J, Killean T, Khalid M, Joshevama E, Diaz E, Martin D, Tsingine K, Karshner T, Albu J, Pi-Sunyer F, Frances S, Maggio C, Ellis E, Bastawrose J, Gong X, Banerji M, August P, Lee M, Lorber D, Brown N, Josephson D, Thomas L, Tsovian M, Cherian A, Jacobson M, Mishko M, Kirkman M, Buse J, Diner J, Dostou J, Machineni S, Young L, Bergamo K, Goley A, Kerr J, Largay J, Guarda S, Cuffee J, Culmer D, Fraser R, Almeida H, Coffer S, Debnam E, Kiker L, Morton S, Josey K, Fuller G, Garvey W, Cherrington A, Dyer D, Lawson M, Griffith O, Agne A, McCullars S, Cohen R, Craig J, Rogge M, Burton K, Kersey K, Wilson C, Lipp S, Vonder Meulen M, Adkins C, Onadeko T, Rasouli N, Baker C, Schroeder E, Razzaghi M, Lyon C, Penaloza R, Underkofler C, Lorch R, Douglass S, Steiner S, Sivitz W, Cline E, Knosp L, McConnell J, Lowe T, Herman W, Pop-Busui R, Tan M, Martin C, Waltje A, Katona A, Goodhall L, Eggleston R, Kuo S, Bojescu S, Bule S, Kessler N, LaSalle E, Whitley K, Seaquist E, Bantle A, Harindhanavudhi T, Kumar A, Redmon B, Bantle J, Coe M, Mech M, Taddese A, Lesne L, Smith S, Desouza C, Kuechenmeister L, Shivaswamy V, Burbach S, Rodriguez M, Seipel K, Alfred A, Morales A, Eggert J, Lord G, Taylor W, Tillson R, Schade D, Adolphe A, Burge M, Duran-Valdez E, Martinez J, Bancroft A, Kunkel S, Ali Jamaleddin Ahmad F, Hernandez McGinnis D, Pucchetti B, Scripsick E, Zamorano A, DeFronzo R, Cersosimo E, Abdul-Ghani M, Triplitt C, Juarez D, Garza R, Verastiqui H, Wright K, Puckett C, Raskin P, Rhee C, Abraham S, Jordan L, Sao S, Morton L, Smith O, Osornio Walker L, Schnurr-Breen L, Ayala R, Kreymer R, Sturgess D, Utzschneider K, Kahn S, Alarcon-Casas Wright L, Boyko E, Tsai E, Trence D, Trikudanathan S, Fattaleh B, Montgomery B, Atkinson K, Kozedub A, Concepcion T, Moak C, Prikhodko N, Rhothisen S, Elasy T, Martin S, Shackelford L, Goidel R, Hinkle N, Lovell C, Myers J, Lipps Hogan J, McGill J, Salam M, Schweiger T, Kissel S, Recklein C, Clifton M, Tamborlane W, Camp A, Gulanski B, Inzucchi S, Pham K, Alguard M, Gatcomb P, Lessard K, Perez M, Iannone L, Magenheimer E, Montosa A, Cefalu W, Fradkin J, Burch H, Bremer A, Nathan D, Lachin J, Kahn S, Krause-Steinrauf H, Larkin M, Tiktin M, Wexler D, Burch H, Younes N, Bebu I, Butera N, Buys C, Fagan A, Gao Y, Ghosh A, Gramzinski M, Hall S, Kazemi E, Legowski E, Liu H, Suratt C, Tripputi M, Arey A, Backman M, Bethepu J, Lund C, Mangat Dhaliwal P, McGee P, Mesimer E, Ngo L, Steffes M, Seegmiller J, Saenger A, Arends V, Gabrielson D, Conner T, Warren S, Day J, Huminik J, Scrymgeour A, Soliman E, Pokharel Y, Zhang Z, Campbell C, Hu J, Keasler L, Hensley S, Li Y, Herman W, Kuo S, Martin C, Waltje A, Mihalcea R, Min D, Perez-Rosas V, Prosser L, Resnicow K, Ye W, Shao H, Zhang P, Luchsinger J, Sanchez D, Assuras S, Groessl E, Sakha F, Chong H, Hillery N. Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort. Diabetes Care 2025, 48: 1960-1970. PMID: 40986645, PMCID: PMC12583396, DOI: 10.2337/dc25-1087.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCardiovascular autonomic neuropathyElectrocardiogram abnormalitiesCardiovascular risk factorsType 2 diabetesHeart rate variabilityRisk factorsAutonomic neuropathyEarly type 2 diabetesTreatment groupsMean diabetes durationBaseline risk factorsGlucose-lowering treatmentGlycemia Reduction ApproachesMeasures of heart rate variabilityCohort of adultsYear 2Diabetes durationInsulin glargineResting electrocardiogramRepeated-measures modelStudy visitsLiraglutideAbnormalitiesGrade cohortsT2D
Clinical Care
Copy Link
Overview
Silvio E. Inzucchi, MD, director of the Yale Medicine Diabetes Center, treats patients who suffer from diabetes as well as pituitary and adrenal disorders. “Endocrinology is fascinating, and we are usually able to help patients improve their quality of life through multidisciplinary care and academic approaches to endocrine conditions,” he says.
Dr. Inzucchi is a professor or medicine (endocrinology) at Yale School of Medicine and the clinical director of the section of endocrinology. In his research, Dr. Inzucchi, studies the cardiovascular effects of diabetes medications and glucose management in the hospital. Named a “top doctor” locally and nationally, Dr. Inzucchi has also received Yale’s David J. Leffell Prize for Clinical Excellence. The prize is given to individuals who demonstrate the highest level of clinical expertise, commitment to teaching and compassion for patients.
He says he has developed an effective personal approach to treating patients, carefully honed over 30 years at Yale. It includes being on top of the latest advances, but also responding to each patient’s individual needs. “I like to try to draw people out in terms of who they are, what’s important to them, their life experiences and their family. Such an approach resonates with patients because they don’t want to be seen as a patient, they want to be treated as a person,” he says.
Clinical Specialties
Fact Sheets
Vitamin D Deficiency
Learn More on Yale MedicineThyroid Nodule
Learn More on Yale MedicineHyperprolactinemia
Learn More on Yale MedicineGoiter
Learn More on Yale Medicine
Board Certifications
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 1988
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews & Links
Copy Link
News
- June 24, 2026
Breaking Down Silos to Understand Cardiometabolic Diseases
- January 27, 2026
Where Community and Academic Medicine Meet
- December 01, 2025
The GLP-1 Revolution
- November 12, 2025
Twenty-Seven YSM Faculty Members Recognized for Highly Cited Research
Get In Touch
Copy Link
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
Events
Yale Only
Yale Only This meeting, by invitation only, is on Zoom.
Yale Only
Yale Only This meeting, by invitation only, is on Zoom.